A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Catalent, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 1,013 shares of CTLT stock, worth $64,305. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,013
Previous 1,048 3.34%
Holding current value
$64,305
Previous $58,000 5.17%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$56.16 - $60.96 $1,965 - $2,133
-35 Reduced 3.34%
1,013 $61,000
Q2 2024

Aug 14, 2024

BUY
$53.58 - $57.02 $321 - $342
6 Added 0.58%
1,048 $58,000
Q1 2024

May 15, 2024

BUY
$42.56 - $59.82 $44,347 - $62,332
1,042 New
1,042 $58.8 Million
Q2 2023

Aug 14, 2024

SELL
$31.86 - $67.26 $2,771 - $5,851
-87 Reduced 34.52%
165 $7.15 Million
Q1 2023

Aug 14, 2024

SELL
$45.44 - $74.26 $22,356 - $36,535
-492 Reduced 66.13%
252 $16.6 Million
Q3 2022

Aug 14, 2024

SELL
$72.36 - $113.1 $29,450 - $46,031
-407 Reduced 35.36%
744 $53.8 Million
Q2 2022

Aug 14, 2024

BUY
$87.2 - $114.05 $3,575 - $4,676
41 Added 3.69%
1,151 $123 Million
Q1 2022

Aug 14, 2024

BUY
$94.19 - $124.49 $5,839 - $7,718
62 Added 5.92%
1,110 $123 Million
Q3 2021

Aug 30, 2024

SELL
$109.17 - $142.35 $86,899 - $113,310
-796 Reduced 58.79%
558 $74.2 Million
Q2 2021

Aug 30, 2024

BUY
$100.34 - $115.69 $30,704 - $35,401
306 Added 29.2%
1,354 $146 Million
Q1 2021

Aug 30, 2024

BUY
$101.51 - $125.27 $81,208 - $100,216
800 Added 59.08%
2,154 $227 Million
Q4 2020

Aug 30, 2024

BUY
$85.88 - $105.36 $116,281 - $142,657
1,354 New
1,354 $141 Million
Q2 2020

Aug 30, 2024

SELL
$48.02 - $79.04 $1,056 - $1,738
-22 Closed
0 $0
Q3 2019

Aug 30, 2024

SELL
$47.45 - $58.05 $48,683 - $59,559
-1,026 Reduced 97.9%
22 $1.05 Million
Q2 2017

Aug 30, 2024

SELL
N/A
-400 Closed
0 $0
Q1 2017

Aug 30, 2024

SELL
N/A
-648
400 $11.3 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.